INDIANAPOLIS, July 8, 2013 /PRNewswire/ --
"I am overwhelmed and humbled by the tremendous support and well-wishes I have received from my friends and fellow Lilly colleagues around the world," Lechleiter said. "I return to Lilly with renewed energy and enthusiasm, along with a new perspective on health and wellness and the critical importance of new medicines in advancing patient care.
"I want to thank and acknowledge Derica Rice for the important role he played during my absence, as well as
Derica W. Rice will continue in his role as executive vice president, global services and chief financial officer. Rice had assumed the additional role of acting chief executive officer during Lechleiter's medical leave.
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered inIndianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. C-LLY
News Provided by Acquire Media